What's in kratom products? Tests find 85% conflict with labels
What's listed on a kratom product label may not tell the full story. Researchers in the University of Florida College of Pharmacy have found that commercially available kratom products, including many kratom-derived products, contain chemical compositions that differ from their labels, highlighting gaps in product transparency and the need for stronger regulation.
Commercially available kratom products often contain chemical compositions that differ from the labels, according to researchers at the University of Florida College of Pharmacy. In a study published in Drug Testing and Analysis, they found that 85% of 44 kratom and kratom-derived products they analyzed had measured chemical compositions inconsistent with their labels.
The discrepancy includes undisclosed alkaloids, mismatched concentrations, and the presence of compounds not listed on the labels. Kratom, a plant native to Southeast Asia, contains over 40 identified alkaloids, some of which interact with human opioid receptors. These compounds vary in chemical structure and may produce different pharmacological effects.
The study emphasizes the need for stronger manufacturing standards, comprehensive testing, and transparent labeling to ensure consumers have accurate information to make informed decisions and mitigate potential safety risks.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
